MDS Provides Update on Timing of Diagnostics Transaction Closing
19 Febbraio 2007 - 1:00PM
PR Newswire (US)
TORONTO, Feb. 19 /PRNewswire-FirstCall/ -- MDS Inc. (TSX:MDS; NYSE:
MDZ), a global life sciences company, provided an update today on
the closing of the sale of its Canadian laboratory services
business, MDS Diagnostic Services, to Borealis Infrastructure
Management Inc. MDS and Borealis Infrastructure Management Inc.
have agreed on a scheduled closing of the transaction on February
23, 2007. About MDS Inc. MDS Inc. (TSX: MDS; NYSE: MDZ) is a global
life sciences company that provides market-leading products and
services that our customers need for the development of drugs and
diagnosis and treatment of disease. We are a leading global
provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments.
MDS has more than 8,800 highly skilled people in 28 countries. Find
out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. DATASOURCE: MDS Inc. CONTACT: Investors: Kim Lee,
Manager, Investor Relations, MDS Inc., (416) 675-6777 x32606, ;
Media: Catherine Melville, Director, External Communications, MDS
Inc., (416) 675-6777 x 32265,
Copyright